Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Q. In a post-accident situation requiring both a company test and a DOT test, which should be conducted first? A. In a post-accident situation in which drug/alcohol testing is required under company authority or policy, and DOT mandated tests are required, the DOT tests must be conducted first. Q. Is failure to check the temperature box on the Drug Testing custody and control form considered a fatal flaw? A. In accordance with 49 CFR part 40 Section 40.65, the collector is to check the temperature of the specimen to ensure the integrity of the specimen. The fact that it was checked should be marked appropriately on the custody and control form. Inadvertently not marking the temperature taken box, in and of itself, does not constitute a “fatal flaw” in the DOT chain of custody process. However, a corrective action on the part of the collector must take place. REPORTING AND REVIEW OF RESULTS Q. When can the MRO notify an employer of a positive drug test result? A. The MRO may not notify the employer of a positive test until he/she has verified the test as positive. Verification requires that the MRO review the chain of custody documentation, contact the employee, offer the employee the opportunity to explain the test result, review any documentation of a legitimate medical explanation for a positive test, and determine that the positive resulted from unauthorized use of a controlled substance. The MRO is not required to delay verification pending the outcome of the split analysis. Upon verification, the MRO shall notify the employer of the positive result, and the employer shall then remove the employee from their safety-sensitive duties/position. Once having received notice of a verified positive result from the MRO, the employer shall not delay removal of the employee from safety-sensitive duties pending the outcome of the reanalysis or the split analysis. In a case where the employee refuses to speak to the MRO, or the MRO and the employer are unable to contact the employee, the MRO may verify the test result without speaking to the employee. Q. Please explain the release of drug test results for unemployment compensation. A. The provisions of 49 CFR part 40 do not permit the employer, simply on the basis of a claim for unemployment compensation being filed, to protest in full from the outset, citing the positive drug test and furnishing all related documents. If the employee’s dismissal is based on misconduct as defined in company policy, and the employee protests the dismissal for cause, the employer may introduce drug test information during the hearing or appeal process as evidence of violation of the company policy prohibiting drug use. The drug testing laboratory may release drug test information to the decision-maker in a proceeding initiated by or on behalf of the employee and arising from a certified positive drug test. Drug test results may be released by the laboratory to the employer at the hearing Appendix G. Questions and Answers G-12 August 2002
or appeal process, but not at the initial filing for benefits. Documentation of the Medical Review Officer’s verification of a certified laboratory result is available to the employer and the employee. The DOT regulations do not require that employees who test positive be discharged, only that they cannot perform safety-sensitive functions until again qualified in accordance with the applicable provisions of the regulations. Accordingly, any decision to discharge an employee who tests positive must be based on some grounds independent of the positive test result (an employer policy, for example). If a discharged employee later asserts in a claim for unemployment compensation that he/she had not violated the company policy on drug use, information about the results of a drug test could be introduced by the employer. Additionally, the DOT has no opinion on the state’s ruling on the employee’s entitlement to unemployment compensation. USE OF DHHS-CERTIFIED LABORATORIES Q. Why use DHHS-certified laboratories? A. DOT requires that all drug testing mandated under the provisions of its drug testing rule must be conducted in DHHS-certified laboratories. DOT decided to require the use of DHHScertified laboratories for drug testing mandate in the regulated industries for several reasons. Most significantly, the DHHS standards for certification and the proficiency testing requirements comprise the most stringent laboratory accreditation program available in analytical forensic toxicology for urine drug testing. Additionally, the DHHS-certification program provides for standardization of laboratory methodology and procedures, ensuring equal treatment of all specimens analyzed. And finally, the use of DHHS-certified laboratories provides a standard that has withstood the test of legal challenges in federal drug testing. Q. Is use of a consortium to conduct random testing allowed? A. The Department allows and even advocates the use of a consortium to assist smaller companies in complying with the current drug testing regulations. While it is true that in a combined employer pool, some employers will have a higher percentage of their employees selected for testing than others in a given 12-month period, over time this will even out. Additionally, the Department believes that the deterrent effect of random drug testing remains as powerful in a combined employers pool as it would be in a stand-alone single company pool. With this in mind, the Department has determined that combining employer pools within a consortium meets the spirit and intent of the drug testing regulations and is, therefore, permissible. Q. Can an employer combine DOT and non-DOT random pools? A. While it would seem advantageous for an employer to combine all employees into one random testing pool, this move could dilute the number of DOT-covered employees who would actually be tested. For example, in a pool that is comprised of 50 DOT-covered Appendix G. Questions and Answers G-13 August 2002
- Page 290 and 291: Other Government Web sites Drug and
- Page 292 and 293: Appendix C Americans with Disabilit
- Page 294 and 295: sensitive duties for the illegal us
- Page 296 and 297: If the individual is qualified and
- Page 298 and 299: allegation of discrimination under
- Page 300 and 301: Appendix D. Certified Laboratories
- Page 302 and 303: DrugProof, Divison of Dynacare 543
- Page 304 and 305: One Source Toxicology Laboratory, I
- Page 306 and 307: The following laboratories are volu
- Page 308 and 309: Federal Register / Vol. 65, No. 141
- Page 310 and 311: Federal Register / Vol. 65, No. 141
- Page 312 and 313: Federal Register / Vol. 65, No. 141
- Page 314 and 315: Appendix F. Fact Sheets Drug Detect
- Page 316 and 317: Social Issues • Two-thirds of all
- Page 318 and 319: • The euphoric stimulation increa
- Page 320 and 321: • Paranoia • Profuse sweating a
- Page 322 and 323: connection between marijuana smokin
- Page 324 and 325: Opiates (Narcotics) Fact Sheet Opia
- Page 326 and 327: Phencyclidine (PCP) Fact Sheet Phen
- Page 328 and 329: Appendix G Questions and Answers
- Page 330 and 331: ecipient, and someone other than th
- Page 332 and 333: Q. Can transit operators receive wa
- Page 334 and 335: Q. If an employee changed jobs prio
- Page 336 and 337: Q. How much training are employers
- Page 338 and 339: acceptable for the company-required
- Page 342 and 343: employees and 50 non-DOT employees,
- Page 344 and 345: Q: What actual address is required
- Page 346 and 347: Q: Can a split specimen be sent to
- Page 348 and 349: actual employee of the employer may
- Page 350 and 351: Q: Must collectors, BATs, STTs, MRO
- Page 352 and 353: an observer, or a monitor for co-wo
- Page 354 and 355: Q: If a collector makes an error on
- Page 356 and 357: Appendix H Terms and Definitions
- Page 358 and 359: indirectly, one controls or has the
- Page 360 and 361: Confirmation validity test Confirme
- Page 362 and 363: These terms include any designee of
- Page 364 and 365: Medical Review Officer (MRO) A pers
- Page 366 and 367: Random test Reason to believe Reaso
- Page 368 and 369: Safety-sensitive function Any of th
- Page 370 and 371: trolley bus, or vessel. A “mass t
- Page 373 and 374: 49 CFR Part 40 Updated August 31, 2
- Page 375 and 376: § 40.89 What is validity testing,
- Page 377 and 378: Page 4 of 100 § 40.287 What inform
- Page 379 and 380: Page 6 of 100 Subpart A - Administr
- Page 381 and 382: Page 8 of 100 Medical Review Office
- Page 383 and 384: Page 10 of 100 § 40.17 Is an emplo
- Page 385 and 386: Page 12 of 100 (b) You must request
- Page 387 and 388: Page 14 of 100 (4) The collector's
- Page 389 and 390: Page 16 of 100 (1) To avoid distrac
Q. In a post-accident situation requiring both a company test and a DOT test, which<br />
should be conducted first?<br />
A. In a post-accident situation in which drug/alcohol testing is required under company<br />
authority or policy, and DOT mandated tests are required, the DOT tests must be conducted<br />
first.<br />
Q. Is failure to check the temperature box on the Drug Testing custody and control form<br />
considered a fatal flaw?<br />
A. In accordance with 49 CFR part 40 Section 40.65, the collector is to check the temperature of<br />
the specimen to ensure the integrity of the specimen. The fact that it was checked should be<br />
marked appropriately on the custody and control form. Inadvertently not marking the<br />
temperature taken box, in and of itself, does not constitute a “fatal flaw” in the DOT chain of<br />
custody process. However, a corrective action on the part of the collector must take place.<br />
REPORTING AND REVIEW OF RESULTS<br />
Q. When can the MRO notify an employer of a positive drug test result?<br />
A. The MRO may not notify the employer of a positive test until he/she has verified the test as<br />
positive. Verification requires that the MRO review the chain of custody documentation,<br />
contact the employee, offer the employee the opportunity to explain the test result, review<br />
any documentation of a legitimate medical explanation for a positive test, and determine that<br />
the positive resulted from unauthorized use of a controlled substance. The MRO is not<br />
required to delay verification pending the outcome of the split analysis. Upon verification,<br />
the MRO shall notify the employer of the positive result, and the employer shall then remove<br />
the employee from their safety-sensitive duties/position. Once having received notice of a<br />
verified positive result from the MRO, the employer shall not delay removal of the employee<br />
from safety-sensitive duties pending the outcome of the reanalysis or the split analysis.<br />
In a case where the employee refuses to speak to the MRO, or the MRO and the employer are<br />
unable to contact the employee, the MRO may verify the test result without speaking to the<br />
employee.<br />
Q. Please explain the release of drug test results for unemployment compensation.<br />
A. The provisions of 49 CFR part 40 do not permit the employer, simply on the basis of a claim<br />
for unemployment compensation being filed, to protest in full from the outset, citing the<br />
positive drug test and furnishing all related documents. If the employee’s dismissal is based<br />
on misconduct as defined in company policy, and the employee protests the dismissal for<br />
cause, the employer may introduce drug test information during the hearing or appeal process<br />
as evidence of violation of the company policy prohibiting drug use.<br />
The drug testing laboratory may release drug test information to the decision-maker in a<br />
proceeding initiated by or on behalf of the employee and arising from a certified positive<br />
drug test. Drug test results may be released by the laboratory to the employer at the hearing<br />
Appendix G. Questions and Answers G-12 August 2002